I thought it was the best presentation they had put out for quite some time. The growth in Metrics Contract Services, Dermatology, International and the potential of Nextstellis does give the company some hope.
Generics is a basket case though. Let's hope in wanes into insignificance over time.
Cheers.....D
- Forums
- ASX - By Stock
- MYX
- Ann: 2022 Half Year Investor Presentation
MYX
mayne pharma group limited
Add to My Watchlist
1.63%
!
$5.00

Ann: 2022 Half Year Investor Presentation, page-18
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.00 |
Change
0.080(1.63%) |
Mkt cap ! $406.2M |
Open | High | Low | Value | Volume |
$4.93 | $5.10 | $4.93 | $3.062M | 610.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 67102 | $5.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.05 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200 | 5.000 |
1 | 4000 | 4.990 |
1 | 1200 | 4.950 |
1 | 870 | 4.940 |
1 | 5000 | 4.930 |
Price($) | Vol. | No. |
---|---|---|
5.050 | 5000 | 1 |
5.100 | 584 | 1 |
5.120 | 2000 | 1 |
5.130 | 600 | 1 |
5.140 | 3111 | 2 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |